Kala Bio Hires Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities

Kala Bio has engaged Dr. Saeid Babaei as a Senior Scientific Advisor to evaluate clinical assets and precision development opportunities. The focus will be on applying AI-enabled analytics and digital health tools to Kala's MSC Secretome platform. The aim is to unlock value through amended indications, assess hypotheses related to potential responder subgroups, and develop a regulatory-conscious analytical framework. The collaboration marks a pivotal step in Kala Bio's strategy to maximize commercial and scientific value.